[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::55647330.png) @AJMC_Journal AJMC

AJMC posts on X about has been, sanofi, women, savings the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::55647330/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::55647330/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXX +211%
- X Months XXXXX -XX%
- X Year XXXXX +60%

### Mentions: X [#](/creator/twitter::55647330/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::55647330/c:line/m:posts_active.svg)

- X Week X +29%
- X Month XX +225%
- X Months XX -XX%
- X Year XX +18%

### Followers: XXXXX [#](/creator/twitter::55647330/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::55647330/c:line/m:followers.svg)

- X Week XXXXX +0.03%
- X Month XXXXX +0.17%
- X Months XXXXX -XXXX%
- X Year XXXXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::55647330/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::55647330/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::55647330/influence)
---

**Social category influence**
[stocks](/list/stocks)  XX%

**Social topic influence**
[has been](/topic/has-been) 10%, [sanofi](/topic/sanofi) 10%, [women](/topic/women) 10%, [savings](/topic/savings) XX%

**Top accounts mentioned or mentioned by**
[@polsinelli](/creator/undefined) [@ppfa](/creator/undefined) [@thealliance](/creator/undefined)

**Top assets mentioned**
[Sanofi (SNY)](/topic/sanofi)
### Top Social Posts [#](/creator/twitter::55647330/posts)
---
Top posts by engagements in the last XX hours

"The potential of health care technology has been disconnected from patients making those innovations barriers rather than means of improving access and communication. Learn more here: #healthcare #technology #healthcareaccess"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1948427991857451016) 2025-07-24 17:00:07 UTC 7161 followers, XX engagements


"Advancements for people with #hemophilia are aimed at reducing treatment burden and providing individualized care including for those with limited options like people living with hemophilia B with inhibitors Sponsored by Sanofi"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1947401196999749822) 2025-07-21 21:00:00 UTC 7161 followers, XX engagements


"New research found that the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with significantly improved survival in women with #ovariancancer. Learn more here: #GLP1 #GLPs"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1943716922689765739) 2025-07-11 17:00:01 UTC 7161 followers, XXX engagements


"Bristol Myers Squibb & Pfizer launch a new direct-to-patient program for #apixaban (Eliquis) offering eligible patients significant savings marking a big step toward making life-saving anticoagulants more affordable for the uninsured and underinsured:"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1946224478700110070) 2025-07-18 15:04:09 UTC 7161 followers, XX engagements


"Today #AJMC begins its coverage of the Society for Pediatric Dermatologys 50th Annual Meeting which will highlight advances in pediatric skin hair and nail care with expert-led sessions on cutting-edge research and therapies. Learn more here:"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1948397870572261534) 2025-07-24 15:00:26 UTC 7161 followers, XX engagements


"#Weightloss drug maridebart cafraglutide (MariTide; Amgen) showed promising results offering a monthly treatment option for #obesity with significant health benefits. Read more:"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1940078942473404586) 2025-07-01 16:03:59 UTC 7161 followers, XX engagements


"Experts discuss the role of implementation science in bridging research and practice with a focus on cardiovascular disease. Learn more in this video from AJMC sponsored by Amgen. Watch here: #sponsored"  
![@AJMC_Journal Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55647330.png) [@AJMC_Journal](/creator/x/AJMC_Journal) on [X](/post/tweet/1942939311978004876) 2025-07-09 13:30:04 UTC 7161 followers, XX engagements